Yin et al. [88] found that EA combined with ovulatory induction drugs significantly improved the menstrual cycle in infertile patients with PCOS, decreased serum LH, LH/FSH, T and AMH levels, and increased ovulation and PRs. Here, BRD2 is linked to polycystic ovary syndrome.